医学
肝移植
移植
钙调神经磷酸酶
肾脏疾病
糖尿病
内科学
肾毒性
肾
肾移植
病因学
疾病
泌尿科
胃肠病学
重症监护医学
内分泌学
作者
Ramon O. Minjares,Paul Martin,Andres F. Carrion
标识
DOI:10.1016/j.cld.2022.01.006
摘要
Improved survival after liver transplantation has led to an aging cohort of recipients at risk of renal dysfunction. The etiology of renal dysfunction is typically multifactorial; calcineurin inhibitors nephrotoxicity, pretransplant renal dysfunction, and perioperative acute kidney injury are important risk factors. Metabolic complications such as hypertension, diabetes mellitus, and metabolic-associated fatty liver disease also contribute to the development of renal disease. Most LT recipients will eventually develop some degree of renal dysfunction. Criteria to select candidates for simultaneous liver and kidney transplantation have been established. Both delayed introduction of CNIs and renal-sparing immunosuppressive regimens may reduce progression of renal dysfunction.
科研通智能强力驱动
Strongly Powered by AbleSci AI